Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease Psychosis”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Not applicableEnded earlyNCT03152292
What this trial is testing

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

Who this might be right for
Parkinson Disease Psychosis
ACADIA Pharmaceuticals Inc. 764
Not applicableUnknownNCT04579887
What this trial is testing

Presence Hallucination in Parkinson's Disease

Who this might be right for
Parkinson Disease Psychosis
Olaf Blanke 10
Post-approval studies (Phase 4)Study completedNCT00095810
What this trial is testing

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychoses
Otsuka Pharmaceutical Development & Commercialization, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT02969369
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 39
Not applicableStudy completedNCT00001320
What this trial is testing

Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients

Who this might be right for
HealthySchizophrenia
National Institute of Mental Health (NIMH) 265
Not applicableStudy completedNCT00360633
What this trial is testing

Psychiatric and Cognitive Manifestations of Parkinson's Disease

Who this might be right for
Parkinson's Disease
NYU Langone Health 36
Testing effectiveness (Phase 2)Study completedNCT02818777
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Colorado, Denver 13
Not applicableStudy completedNCT00024622
What this trial is testing

PET Scanning in Parkinson s Disease

Who this might be right for
SchizophreniaParkinson's Disease
National Institute of Mental Health (NIMH) 502
Not applicableLooking for participantsNCT07509125
What this trial is testing

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

Who this might be right for
Alzheimer Dementia (AD)ALS - Amyotrophic Lateral SclerosisParkinson s Disease+7 more
Universitaire Ziekenhuizen KU Leuven 300
Post-approval studies (Phase 4)Looking for participantsNCT04373317
What this trial is testing

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Who this might be right for
Parkinson's Disease Psychosis
VA Office of Research and Development 358
Post-approval studies (Phase 4)Looking for participantsNCT05590637
What this trial is testing

Comparing Antipsychotic Medications in LBD Over Time

Who this might be right for
Parkinson's Disease PsychosisDementia With Lewy Bodies
The University of Texas Health Science Center at San Antonio 94
Testing effectiveness (Phase 2)Study completedNCT00087542
What this trial is testing

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Who this might be right for
HallucinationsPsychosesParkinson's Disease
ACADIA Pharmaceuticals Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00009048
What this trial is testing

EMD 128130 for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 30
Testing effectiveness (Phase 2)Study completedNCT00125138
What this trial is testing

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychotic Disorders
Lundbeck LLC 90
Not applicableStudy completedNCT05240339
What this trial is testing

Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)

Who this might be right for
Parkinson DiseaseParkinson Disease PsychosisHallucinations+1 more
University of Rochester 38
Large-scale testing (Phase 3)Study completedNCT00658567
What this trial is testing

Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 123
Very early researchUnknownNCT03661125
What this trial is testing

SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
King's College London 30
Large-scale testing (Phase 3)Study completedNCT00550238
What this trial is testing

The Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 459
Post-approval studies (Phase 4)Study completedNCT04292223
What this trial is testing

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
ACADIA Pharmaceuticals Inc. 29
Load More Results